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a  b  s  t  r  a  c  t
This  work  deals  with  the  preparation  of  chitosan/tripolyphosphate  microparticles  (CHT/TPP)  using
microemulsion  system  based  on water/benzyl  alcohol.  The  morphology  of the  microparticles  was  eval-
uated  by  scanning  electron  microscopy  (SEM).  The  microparticles  were  also  characterized  through
infrared  spectroscopy  (FTIR)  and  wide-angle  X-ray  scattering  (WAXS).  The  morphology  and  crystallinity
of  microparticles  depended  mainly  on  CHT/TPP  ratio.  Studies  of  controlled  release  of  HP were  evaluatedeywords:
hitosan
eparin
ontrolled release
ripolyphosphate
in distilled  water  and  in  simulated  gastric  ﬂuid.  Besides,  the proﬁle  of  HP releasing  could  be tailored  by
tuning the CHT/TPP  molar  ratio.  Finally,  these  prospective  results  allow  the  particles  to  be  employed  as
site-speciﬁc  HP  controlled  release  system.
© 2012 Elsevier B.V. Open access under the Elsevier OA license. icroparticles
. Introduction
Chitosan (CHT) is a non-toxic polymer obtained from deacetyla-
ion of chitin [1,2]. This polymer presents excellent biocompatibil-
ty, biodegradability and antimicrobial activity [3].  Thus, CHT has
een studied for many medical applications such as tissue engi-
eering and drug delivery systems [1–6]. As the CHT possesses
igher adsorption capacity than chitin, therefore, the CHT-based
aterials could be utilized in water puriﬁcation systems [7].  The
PP is a non-toxic polyanion which interacts with CHT through
lectrostatic forces. The protonated amine groups in CHT interact
ith the negatively charged ions on TPP through ionic interactions
reating ionic cross-linked networks [8–10]. Microparticles of CHT
rosslinked with tripolyphosphate (TPP) showed signiﬁcant results
n adsorption of ions Copper(II) [8],  Lead(II) [9] and Uranium [10].
In the intestinal environment, CHT/TPP particles showed
otential for speciﬁc delivering of Papain [11], Acyclovir (antivi-
al drug) [12] and polyphenolic antioxidants, such as Catechin
13]. Chitosan/cyclodextrin nanoparticles were also used as
evices for controlled release of heparin (HP) [14]. The low
ncapsulation efﬁciency and high association of the drug with chi-
osan/cyclodextrin nanoparticles impaired the release of HP [14].
hitosan/genipin microspheres showed potential for speciﬁc deliv-
ring of low molecular weight heparin (LMWHP) in the region of the
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E-mail address: afmartins50@yahoo.com.br (A.F. Martins).
141-8130 ©  2012 Elsevier B.V. 
ttp://dx.doi.org/10.1016/j.ijbiomac.2012.08.032
Open access under the Elsevier OA license. gastrointestinal tract [15]. However, it is known that LMWHP  does
not present effective anticoagulant activity [16].
The molecule of HP consists of sulfated d-glucosamine units,
joined in alternating sequence by (1,4)-glycosidic linkages, to
either d-glucuronic and l-iduronic acid [17–19].  Due to the pres-
ence of carboxyl and sulfate groups, HP has the highest negative
charge density of any known biological polyanion [19]. The HP
presents interesting properties such as biodegradability, biocom-
patibility, stimulates cell growth and inhibits blood coagulation, so
it is widely used in pharmaceutical and medical ﬁelds [3,17,18].
The aims of this study were to obtain CHT/TPP particles through
microemulsion method at different pH and CHT/TPP ratios, using
the system water/benzyl alcohol, to encapsulate the HP on such
particles and to evaluate the proﬁles of HP release at different pH
conditions.
2. Experimental
2.1. Materials
Chitosan (CAS 9012-76-4) with deacetylation degree equal
to 85% and average molecular weight of 87 × 103 g mol−1 was
purchased from Golden-Shell Biochemical (China); benzyl alco-
hol (CAS 100-51-6) and methylene blue (CAS 97130-83-1) were
both purchased from Sigma; sodium tripolyphosphate (85%) (CAS
9010-08-6) was  purchased from Acros (New Jersey, USA). Heparin
sodium (CAS 9041-08-1) was kindly supplied by Kin Master (Passo
Fundo, Brazil). Other reactants such as, sodium hydroxide, sodium
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Table 1
Composition of the microemulsion system (W/BnOH): the volumes of each solution,
CHT/TPP molar ratio and pHs used to obtain of the particles.
CHT/TPP molar ratio
15/1 (pH 2) 9/1 (pH 2) 15/1 (pH 5) 9/1 (pH 5)
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from the following equation:CHT (cm−3) 20 20 20 20
TPP (cm−3) 3 5 3 5
hloride, hydrochloric acid, ethanol and acetone were also utilized
n this work. All reactants were used as received, thus without
urther puriﬁcation.
.2. Particles preparation
Particles of CHT/TPP were prepared based on a microemulsion
ystem using water/benzyl alcohol (W/BnOH) [20]. For preparing
he CHT/TPP particles, separated solutions (20 cm−3) of CHT (0.4 g
r 2.48 mmol  per repeating unit, being considered only the deacety-
ated residues) and TPP (0.47 g or 1.09 mmol) at 2.0 wt.%/vol.% were
repared at pH 2 and pH 5. The pH was adjusted by either sodium
ydroxide or hydrochloric acid (1.0 or 0.10 mol  L−1) solutions. The
reviously prepared solution of CHT (20 cm−3) was mixed with
enzyl alcohol keeping the volume ratio at 1/4 (W/BnOH). The mix-
ure was initially kept under stirring at 6000 rpm during 10 min  and
hen increased to 14,000 rpm. Afterwards, 3.0 or 5.0 cm−3 (TPP solu-
ion) was slowly dripped and the system was kept under stirring by
urther 10 min. Finally, the particles of CHT/TPP were precipitated
nd washed in acetone, vacuum ﬁltered and dried at 30 ◦C for 24 h.
he volume of each solution and CHT/TPP molar ratios, as well as
he pH in which the particles were prepared are summarized in
able 1. The label CHT/TPPx–y was used for correlating the pH(x)
nd volume (y) of TPP solution, used for preparing the particles, to
he studied properties.
.3. Particles characterization
.3.1. Scanning electron microscopy (SEM)
The morphology of particles was investigated through analy-
is of SEM images (Shimadzu, model SS 550). The particles were
putter-coated with a thin layer of gold for allowing the SEM
isualization. Images were taken by applying an electron beam
ccelerating voltage of 10–15 kV. The particles average diameters
ere calculated by analysis of SEM images using the software Size
eter©, version 1.1 with differentiation threshold set according to
he image scale.
.3.2. Wide angle X-ray scattering (WAXS)
The WAXS proﬁles were recorded on a diffractometer Shimadzu
odel XRD-600 equipped with a Ni-ﬁltered Cu-K radiation. The
AXS proﬁles were collected in the scattering range 2 = 5–70◦,
ith resolution of 0.02◦, at a scanning speed of 2◦ min−1. The anal-
ses were performed by applying an accelerating voltage of 40 kV
nd a current intensity of 30 mA.
.3.3. Fourier-transform infrared spectroscopy (FTIR)
FTIR spectra were recorded using a Fourier transform infrared
pectrophotometer (Shimadzu Scientiﬁc Instruments, Model 8300,
apan), operating from 4000 to 500 cm−1, at resolution of 4 cm−1.
TIR spectra were obtained from KBr pellets. For comparison, the
aw CHT and HP were also characterized by the FTIR technique..4. Loading of HP on CHT/TPP particles
1.0 g of each sample (CHT/TPPx–y  particles) was  dispersed in
a. 90 cm3 of HCl/H2O solution at (pH 2 or pH 5) under stirringal Macromolecules 51 (2012) 1127– 1133
at 1000 rpm. Just after, 10 cm3 of HP solution (1.0 mg cm−3) was
slowly dripped. The system was  kept under stirring (1000 rpm) over
24 h at room temperature. So, the loaded particles were removed by
centrifugation (14,000 rpm) at 4 ◦C, vacuum ﬁltered, washed with
ethanol and lyophilized for 24 h at −55 ◦C. The supernatant was
analyzed through UV spectroscopy technique (at  = 567 nm using
a UV-Vis Femto, model 800Xi, Brazil) to estimate the loading efﬁ-
ciency. Aliquots of 100 L of supernatant were directly added to
4.0 cm3 of an aqueous solution of methylene blue (MB) (5.0 mg  L−1),
according to methodology described by Farndale et al. [21] and
Martins et al. [3].  The measurements of absorbance of the complex
MB/HP were performed immediately after homogenization of the
samples that occurred quickly after mixing. Using a previously built
analytical curve, the concentration of HP remained in the super-
natant was calculated [3].  The analytical curve was designed from
standard HP solutions varying from 0.20 to 7.0 mg L−1 using dis-
tilled water as solvent (pH ≈ 5.5–6.0). Such analytical curve was
made based on increasing absorbance of the complex of MB/HP
with increasing concentration of HP. The value of linear correla-
tion coefﬁcient (R2) for such curve was  0.987. The encapsulation
efﬁciency was  calculated using the following equation:
Encapsulation efﬁciency = [HPi] − [HPs]
[HPi]
× 100% (1)
where [HPi] is initial amount of heparin and [HPs] is the amount of
heparin in the supernatant.
2.5. Characterization of the loaded particles
2.5.1. FTIR spectroscopy
The HP-loaded CHT–TPP particles were also characterized by
FTIR spectroscopy in the same way  as already described for non-
loaded particles.
2.5.2. Thermogravimetric (TGA/DTG) analysis
TGA was performed from 25 ◦C to 750 ◦C at a heating rate of
10 ◦C min−1 under N2(g) ﬂowing at 50 mL  min−1 in a TGA-50 Ther-
mogravimetry Analyzer (Netzch, model STA 409PG/4/G Luxx, USA).
2.6. In vitro heparin (HP) release
The in vitro HP release studies were performed in two  dif-
ferent environments: simulated gastric ﬂuid (SGF, 2.0 g NaCl and
7.0 cm−3 HCl in 1000 cm−3 of water, pH 1.2) and distilled water
(pH ≈ 5.5–6.0), both without the presence of enzymes. In a dissolu-
tor apparatus, 0.20 g of loaded particles were deposited in a sealed
ﬂask with 50 cm−3 of SGF or distilled water under constant stirring
(60 rpm), at 37 ◦C. At a desired time interval, an aliquot (100 L)
was removed from the ﬂask and directly added to 4.0 cm3 of aque-
ous MB  solution (5.0 mg  L−1), to quantify the released amount of
drug through UV measures, as described in Section 2.4.  In this case,
analytical curve for HP solution at SGF and at distilled water were
built in the HP conc. range of 0.20–7.0 mg  L−1 [3,21]. The linear cor-
relation coefﬁcient (R2) for the analytical curve using the SGF as
solvent was  of 0.986. The fraction released of HP was  calculatedFraction released = amount released
amount encapsulated
× 100% (2)
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. Results and discussion
.1. Particles characterization
.1.1. Scanning electron microscopy (SEM)
SEM images in Figs. 1 and 2 allow observing that the morphology
f obtained particles is dependent on CHT/TPP molar ratio and on
H of feed solution. The lower CHT/TPP ratio at pH 2 (see Table 1)
id not favor the formation of small particles due to coalescence
ut favors, in fact, irregularly shaped large clusters, as showed in
ig. 1c and d. Therefore, those samples were not used for further
tudies in this work. The values of averaged particles size obtained
fter different runs are presented in Table 2.
The samples obtained from feed solution at pH 5, CHT/TPP5–3
nd CHT/TPP5–5, did not coalesce as those prepared at pH 2 (com-
are the Figs. 1 and 2). However, it could be veriﬁed that the lower
HT/TPP molar ratio (at pH 5) favors the formation of more com-
acted particles; see Fig. 2a–c. Therefore, the CHT/TPP ratio and the
H clearly inﬂuenced the size and porosity of obtained particles. In
eneral, the CHT/TPP particles presented irregular shape.
.1.2. WAXS proﬁles
Fig. 3 shows the WAXS proﬁles of CHT and of CHT/TPP particles athree different formulations. One could observe the CHT/TPP par-
icles showed important differences in the crystallinity proﬁle as
ompared to pure CHT. The diffraction peaks that appear in WAXS
roﬁle of CHT (Fig. 3a) at 2 = 10.5◦, 19.9◦, 43.9◦ and 64.3◦ were
able 2
verage size of CHT/TPP particles.
Particles Particles size (m)
3 cm−3 (TPP) 5 cm−3 (TPP)
CHT/TPP2 9.23 ± 3.8 –
CHT/TPP5 7.26 ± 2.3 10.56 ± 4.2 b) and CHT/TPP2–5 (c and d) particles.
attributed to the crystalline regions formed by hydrogen bonds
among the amino and hydroxyl groups on CHT chains [17,22].  It is
possible to verify on proﬁles presented in Fig. 3 that the CHT/TPP2–3
and CHT/TPP5–3 particles presented higher crystallinity than the
CHT/TPP5–5 ones, fact directly associated to CHT/TPP molar ratio.
The lower crosslinking density (related to the used amount of TPP)
the higher is the CHT chains mobility, feature that contributes to the
reorganization of CHT chains during the formation of CHT/TPP2–3
and CHT/TPP5–3 particles.
The CHT chains reorganization is evidenced by the intense peaks
that appear at 2 = 12.2◦, 44.0◦ and 64.5◦ (Fig. 3, curves b and c
on). Piai et al. [22] and Fajardo et al. [23] observed reorganiza-
tion in polyelectrolyte complexes (PECs) constituted by CHT and
chondroitin sulfate by analyzing the diffraction peaks at 2 = 43.8◦
and 64.2◦ in WAXS proﬁle of such PECs. The high intensity of such
new peaks in Fig. 3, related to WAXS proﬁle of raw CHT (curve a),
was attributed to the large extension of H-bonds among CHT–CHT,
CHT–TPP and TPP–TPP chain segments. Unlike the amino groups
of CHT, which possessed pKa ≈ 6.5, the TPP anion presents ﬁve
pKa (pKa1 = 1.0, pKa2 = 2.0, pKa3 = 2.79, pKa4 = 6.47 and pKa5 = 9.24),
according to Shu and Zhu [24]. So, the TPP anion can contribute
to the increase the intermolecular forces in the CHT/TPP particles,
since not all of phosphate groups are ionized in acid medium [24].
Fig. 4 depicts the proposed scheme for the aforementioned
interactions. In light of this, the reorganization of CHT chains is
favored when the used amount of TPP is not enough to neutralize
the density of positive charges on CHT, that prevail as +NH3.
Besides, the large extent of positive charges due to the high
CHT/TPP molar ratio on CHT/TPP2–3 and CHT/TPP5–3 particles
could induce the appearance of domains with electrostatic repul-
sion (Fig. 4). These repulsion sites could be minimized with
structural reorganization process increasing the density of interac-
tions through H-bonds on CHT/TPP2–3 and CHT/TPP5–3 particles
(Fig. 4). This fact would explain the higher crystallinity of those
samples related to CHT/TPP5–5.
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(Fig. 2. SEM images of the CHT/TPP5–3 
On the other hand, from the curve (d) on Fig. 3, it is possible
o observe that CHT/TPP5–5 particles are mostly amorphous, fact
roved by the occurrence of a halo with maximum at 2 = 21.8◦ and
lso by the absence of peaks at 2 = 12.2◦, 44.0◦ and 64.5◦, as com-
ared to the WAXS proﬁles (curves b and c). In this way, the higher
mount of TPP used in preparation of CHT/TPP particles (Table 1)
he higher is the density of physical crosslinking. This fact provides
arger rigidity of the chains, which hinders the reorganization of
HT chains in CHT/TPP5–5 particles.
From the analysis of SEM image from CHT/TPP5–5 particles
Fig. 2d), one can be inferred that the higher content of TPP
5.0 cm−3) provides rigidity to the CHT chains preventing its
Fig. 3. WAXS proﬁles of precursors (CHT and TPP) and CHT/TPP particles. b) and CHT/TPP5–5 (c and d) particles.
structural reorganization and leading to particles with highly
uneven shape. Therefore, the low crystallinity and high roughness
of CHT/TPP5–5 sample, in relation to the others, was mainly due
to its low CHT/TPP molar ratio.
Additionally, the structural reorganization observed in the
WAXS proﬁles (curves b and c) was conﬁrmed by the absences of
the diffractions peaks at 2 = 44.0◦ and 64.5◦ in WAXS proﬁle of
pure sodium tripolyphosphate (curve e).
3.1.3. FTIR spectroscopy
The CHT/TPP particles were characterized through FTIR spec-
troscopy, and the spectra are presented in Fig. 5. The FTIR spectrum
of pure sodium tripolyphosphate (Fig. 5a) showed characteristic
bands at 1218 (P O stretching), 1156 (symmetrical and asymmet-
ric stretching vibration of the PO2 groups), 1094 (symmetric and
asymmetric stretching vibration of the PO3 groups) and 892 cm−1
(P O P asymmetric stretching) [25].
The main differences in the FTIR spectra of the particles related
to FTIR spectrum of raw CHT, refers to the weak bands at 1250 cm−1
and 1218 cm−1 which can be assigned to P O stretching vibration
and the band at 892 cm−1 attributed to P O P asymmetric stretch-
ing (Fig. 5b–d). These signals indicate the presence of phosphate
groups in the CHT/TPP particles [11,25,26].  The band at 1079 cm−1,
attributed to stretching of C O bonds of primary alcohols (Fig. 5e),
presented noticeable differences in comparison to the FTIR spec-
tra of the particles (Fig. 5b–d). These differences were mainly due
to complexation among CHT and TPP molecules [11]. The band
at 1600 cm−1 that appears on CHT spectrum (Fig. 5e), attributed
to N H deformation of amine groups, is absent in the spectrum
of CHT/TPP particles and a new band at 1523 cm−1, assigned to
+NH3, can be observed [11,26]. Therefore, from this spectral infor-
mation, it can be concluded that the crosslinking was effective
through ionic interactions among negatively charged P O− moi-
eties of the phosphate groups of TPP and protonated +NH3 moieties
of CHT chains. The, small differences in the FTIR spectra (range from
A.F. Martins et al. / International Journal of Biological Macromolecules 51 (2012) 1127– 1133 1131
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on HP [3].  The bands at 1521 cm−1 and 1637 cm−1 showed some
variations in intensity; however this fact was associated with the
weight of particles in the KBr pellets. In light of this, it is suggestedFig. 5. FTIR spectrum of (a) TPP, (b–d) CHT/TPP particles and (e) CHT.
250 to 3750 cm−1) of the particles related to FTIR spectrum of CHT
ere assigned to the diversities in the H-bonds intensities among
HT–TPP and TPP–TPP chain segments. However, these spectral
ifferences were subtle, since the H-bonds between the amino and
ydroxyl groups on the CHT chains also are extremely pronounced,
s related in Section 3.1.1.
.2. Particles loading
.2.1. Efﬁciency
The efﬁciency of HP loading was ca. 99% for all samples (Table 3)
o important is the pH of solution used for loading neither the
HT/TPP ratio used during the particles preparation. This means
hat the natively charged HP would interact with remaining pos-
tive sites on CHT/TPP particles. The efﬁciency of HP loading was
btained according to methodology described by Martins et al. [3].
able 3
eparin encapsulation efﬁciency for various particles compositions (n = 2).
Particles Encapsulation efﬁciency (%)
CHT/TPP2–3 99.0 ± 0.21
CHT/TPP5–3 99.2 ± 0.19
CHT/TPP5–5 99.4 ± 0.15bly of CHT chains in CHT/TPP2–3 and CHT/TPP5–3 particles.
3.2.2. FTIR spectroscopy of HP-loaded particles
The HP-loaded CHT/TPP particles (CHT/TPP2–3/HP, CHT/TPP5-
3/HP and CHT/TPP5-5/HP) were characterized by FTIR, as presented
in Fig. 6. It is possible to observe clear spectral changes due to
the incorporation of HP comparing the FTIR spectra of loaded and
unloaded CHT/TPP2–3 particles (spectra i and a, respectively, Fig. 6).
Firstly, the enlargement of the band at 1238 cm−1 (Fig. 6i) was
attributed to the axial deformation of S O groups from the saccha-
ride structure of HP (Fig. 6d) [3].  Besides, a broadening in the region
from 2500 cm−1 to 3500 cm−1 can be also veriﬁed. It is worthy to
mention that at pH 2, the CHT chains present high density of pos-
itive charges, which strongly contributes to ionic association with
polyanions [3,27].  This set of information conﬁrms the HP encap-
sulation and also suggests that at pH 2 there is stronger association
among HP chains and CHT/TPP2–3 particles than at pH 5, probably
due to existing H-bonds and electrostatic interactions among +NH3
and OSO3− groups. This explains, for instance, the high efﬁciency
in loading the HP on CHT/TPP particles.
On the other hand, the FTIR spectra for the loaded and unloaded
particles prepared at pH 5 did not show any important difference.
The only variation to be mentioned is the increase in intensity of
the band at 2934 cm−1 attributed to the C H axial deformationFig. 6. FTIR spectra of CHT/TPP particles (a–c); CHT/TPP particles with loaded HP
(i–iii); and HP (d).
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hat HP is mainly adsorbed in the surface of obtained particles. On
ther hand, the small differences in the FTIR spectra (Fig. 6) were
ainly due to low weight proportion of HP on the loaded parti-
les, when compared to the unloaded samples. For each 1.0 g of
article, only 9.9 mg  of HP were loaded. Therefore, the small differ-
nces observed in the FTIR spectra (Fig. 6) were attributed to the
P-loading process.
.2.3. Thermal stability of particles (TGA/DTG analysis)
The TGA curves from CHT/TPP and CHT/TPP/HP particles are
resented Fig. 7a. It could be observed two thermal events of
eight loss in each curve. The ﬁrst one was attributed to the
oss of water and also of volatile compounds. The CHT/TPP2–3,
HT/TPP5–3 and CHT/TPP5–5 particles presented similar amounts
f adsorbed water, ca. 11 wt%. However, the samples CHT/TPP
howed different water content than CHT/TPP/HP ones. The HP
ncorporation decreased the water content of the samples. This
act was stronger in the CHT/TPP2–3/HP and CHT/TPP5–3/HP sam-
les. The sulphonate groups ( OSO3−) present in the HP structure
trongly interact to +NH3 groups from CHT, decreasing the interac-
ion (H-bond, dipole–dipole and ion–dipole) intensity among water
olecules and CHT chains.
The TGA proﬁles from the CHT/TPP5–5 and CHT/TPP5–5/HP are
ery similar mainly if the ﬁrst thermal event is taken into account.
his information correlates to those from WAXS proﬁles (Fig. 3).
he non reorganization of CHT chains in the CHT/TPP5–5 particles
Fig. 8. Fraction of HP released from CHT/TPP parnd CHT/TPP particles with loaded HP.
indicates that the polysaccharide segments are not enough avail-
able for interacting to water molecules as probably occurred in the
other samples.
The ﬁrst derivatives of degradation stage (second event on TGA
curves) for CHT/TPP and CHT/TPP/HP are presented in Fig. 7b. It
is possible to observe that samples presented different degrada-
tion temperatures, as indicated by the inﬂexion points in the DTG
curves. This fact reinforces the HP encapsulation. The samples
CHT/TPP2–3, CHT/TPP5–3 and CHT/TPP5–3 showed degradation
temperatures of 241 ◦C, 251 ◦C and 248 ◦C, respectively. These dif-
ferences were attributed mainly to the pH in which the particles
were prepared. At low pH condition, the TPP did not stabilize the
excess of +NH3 groups on CHT. So, there are domains in which
the electrostatic repulsion (see Fig. 4) prevails, contributing to less
packed structure, which provides to CHT/TPP2–3 lower thermal
stability compared to the other two  samples.
The adsorption of HP by the CHT/TPP2–3 particles raises the
thermal stability in ca. 6 ◦C, from 241 ◦C to 247 ◦C. This fact was
due to the further neutralization of remaining positive charges on
CHT by HP that also provides extra H-bonds allowing increasing the
thermal stability of CHT/TPP/HP2–3 sample.
On the other hand, the thermal stability of CHT/TPP5–3
decreased from 251 ◦C to 244 ◦C due to the encapsulation of HP
(CHT/TPP5–3/HP). At pH 5, the presence of COO− and OSO3− groups
on HP allows repulsion on composite material leading to a smaller
thermal stability compared to not HP-loaded particles. Finally, it
ticles in distilled water (a) and in SGF (b).
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an be seen that the incorporation of HP on CHT/TPP5–5 parti-
les practically did not affect the thermal stability of the sample
inﬂection point of TGA for CHT/TPP5–5 occurs at 248 ◦C and for
HT/TPP5–5/HP occurs at 249 ◦C).
As reported previously, for each 1.0 g of particle, only 9.9 mg  of
P were loaded. Therefore, the weight ratio particle/HP is ca. 100/1
nd TGA/DTG analyses were processed with only 6.0 mg  of each
ample (CHT/TPP loaded with HP and CHT/TPP unloaded). Thus,
he small differences observed in Fig. 7 occur due to low weight
f HP on the CHT/TPP loaded particles, when compared to the
HT/TPP unloaded samples. Thus, the subtle differences observed
n the TGA/DTG curves also were assigned to the HP-loading
rocess.
.3. “In vitro” release studies
The fractions of HP released from CHT/TPP particles in distilled
ater and in SGF are presented in Fig. 8a and b, respectively. Consid-
ring the CHT/TPP5–3 particles, it was veriﬁed that the maximum
raction of HP released in distilled water was  ca. 17% and it is
chieved under 2 h (Fig. 8a) after the test has been initiated. This
esult shows that CHT/TPP5–3 particles present great potential to
e used as device for sustained release of HP at neutral pH, and the
lmost same condition found in intestinal region.
The structure-loosing was due to the lower amount of TPP, the
rosslinking agent used for preparing the CHT/TPP5–3 particles,
nd the pH close to 7 favored the HP releasing. An opposite charac-
eristic was found for CHT/TPP2–3. This behavior can be understood
y the higher association of the drug (HP) to the CHT/TPP parti-
les obtained at pH 2, as previously discussed. The proﬁle of HP
eleased in SGF is presented in Fig. 8b. The particles presented sta-
ility in SGF and the extension of HP releasing was  not as high as
as observed in distilled water. Considering the CHT/TPP5–5 par-
icles, the maximum releasing was 5% in SGF, for the ﬁrst 1 h of
nalysis.
Following the same trend, CHT/TPP5–3 particles released only
.5% of total loaded HP, while in distilled water the fraction of HP
eleased was 17%. Therefore, the CHT/TPP microparticles could be
uccessful used as site-speciﬁc drug delivery of HP in the intestinal
egion, especially the CHT/TPP5–3 particles.
. Conclusions
CHT/TPP particles were successfully obtained from the
icroemulsion method (W/BnOH) at different CHT/TPP ratios and
H conditions. The particles were characterized by SEM, FTIR spec-
roscopy and WAXS. The morphology and crystallinity of particles
epend mainly on CHT/TPP ratio. The HP encapsulation was ca. 99%
or all tested samples as conﬁrmed by TGA and FTIR techniques.
ssays of controlled release of HP showed that CHT/TPP particles
ave high stability in SGF environment and in that condition the
eleasing of HP was minimized. On the other hand, in distilled water
[
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the CHT/TPP5–3 particles released ca. 17% (or 660 UI  kg−1) of the
initially loaded HP. Therefore, CHT/TPP5–3 particles could act as a
device for speciﬁc drug delivering of HP in the colon region. This
study showed that the fraction of HP released could be tailored by
tuning the amount of TPP used in the particles preparation. In light
of this, lower CHT/TPP ratios could improve the extension of HP
released from CHT/TPP particles at pH 5.
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